carboxyamido-triazole has been researched along with Carcinoma, Lewis Lung in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, C; Chen, W; Guo, L; Ju, R; Li, J; Shi, J; Sun, F; Ye, C; Zhang, D; Zhu, L | 1 |
Chen, C; Chen, W; Guo, L; Ju, R; Li, J; Ye, CY; Zhang, DC; Zhu, L | 1 |
Guo, L; Ju, R; Li, J; Wu, D; Ye, C; Zhang, D | 1 |
Ara, G; Chen, YN; Holden, SA; Korbut, TT; Northey, D; Teicher, BA | 1 |
4 other study(ies) available for carboxyamido-triazole and Carcinoma, Lewis Lung
Article | Year |
---|---|
Carboxyamidotriazole Synergizes with Sorafenib to Combat Non-Small Cell Lung Cancer through Inhibition of NANOG and Aggravation of Apoptosis.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Drug Synergism; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Nanog Homeobox Protein; Niacinamide; Phenylurea Compounds; Sorafenib; Triazoles; Xenograft Model Antitumor Assays | 2017 |
Carboxyamidotriazole alleviates muscle atrophy in tumor-bearing mice by inhibiting NF-κB and activating SIRT1.
Topics: Adipose Tissue; Animals; Antineoplastic Agents; Cachexia; Carcinoma, Lewis Lung; Interleukin-6; Male; Mice, Inbred C57BL; Muscle, Skeletal; Muscular Atrophy; NF-kappa B; Sirtuin 1; Triazoles; Tumor Burden; Tumor Necrosis Factor-alpha | 2017 |
Inhibition of pro-inflammatory cytokines in tumour associated macrophages is a potential anti-cancer mechanism of carboxyamidotriazole.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Experimental; Carcinoma, Lewis Lung; Coculture Techniques; Cytokines; Dexamethasone; Macrophages; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms; Rats, Wistar; Triazoles; Tumor Microenvironment; Tumor Necrosis Factor-alpha | 2012 |
CAI: effects on cytotoxic therapies in vitro and in vivo.
Topics: Aminoimidazole Carboxamide; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Carmustine; Cisplatin; Cyclophosphamide; Fibrosarcoma; Mammary Neoplasms, Experimental; Melphalan; Mice; Triazoles; Tumor Cells, Cultured | 1994 |